ImpediMed Limited (ASX:IPD) Conclusion of Study Supports Business Model In The Use of L-Dex U400 For Treatment of Lympho

  Brisbane, Australia, Mar 19, 2009 - (ABN Newswire) - ImpediMed Limited (ASX:IPD) would like to bring to the attention of all shareholders the publication: & quot;Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study & quot;, published on the 16th March 2009 in the online edition of the Journal of Clinical Oncology.  

Sydney

  [ Change ]
 
Today

Min: 13°
Max: 19°
Possible morning shower.
Tomorrow

Min: 12°
Max: 20°
Possible shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online